{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:35:09Z","timestamp":1791477309044,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00467-019-04399-0","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T23:03:34Z","timestamp":1576019014000},"page":"485-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-7813","authenticated-orcid":false,"given":"Dieter","family":"Haffner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Leifheit-Nestler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"4399_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G, Kidney Disease: Improving Global Outcomes (KDIGO) (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"4399_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"MC Hu","year":"2013","unstructured":"Hu MC, Shiizaki K, Kuro-o M, Moe OW (2013) Fibroblast growth factor 23 and klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 75:503\u2013533","journal-title":"Annu Rev Physiol"},{"key":"4399_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2215\/CJN.05840513","volume":"9","author":"AA Portale","year":"2014","unstructured":"Portale AA, Wolf M, Juppner H, Messinger S, Kumar J, Wesseling-Perry K, Schwartz GJ, Furth SL, Warady BA, Salusky IB (2014) Disordered FGF23 and mineral metabolism in children with CKD. Clin J Am Soc Nephrol 9:344\u2013353","journal-title":"Clin J Am Soc Nephrol"},{"key":"4399_CR4","first-page":"303","volume":"24","author":"KA Hruska","year":"2015","unstructured":"Hruska KA, Seifert M, Sugatani T (2015) Pathophysiology of the chronic kidney disease-mineral bone disorder. Curr Opin Nephrol Hypertens 24:303\u2013309","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"4399_CR5","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.2215\/CJN.05990710","volume":"6","author":"SA Bakkaloglu","year":"2011","unstructured":"Bakkaloglu SA, Borzych D, Soo Ha I, Serdaroglu E, Buscher R, Salas P, Patel H, Drozdz D, Vondrak K, Watanabe A, Villagra J, Yavascan O, Valenzuela M, Gipson D, Ng KH, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network (2011) Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the international pediatric peritoneal dialysis network (IPPN) registry. Clin J Am Soc Nephrol 6:1926\u20131933","journal-title":"Clin J Am Soc Nephrol"},{"key":"4399_CR6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ki.2010.316","volume":"78","author":"D Borzych","year":"2010","unstructured":"Borzych D, Rees L, Ha IS, Chua A, Valles PG, Lipka M, Zambrano P, Ahlenstiel T, Bakkaloglu SA, Spizzirri AP, Lopez L, Ozaltin F, Printza N, Hari P, Klaus G, Bak M, Vogel A, Ariceta G, Yap HK, Warady BA, Schaefer F, International Pediatric PD Network (IPPN) (2010) The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int 78:1295\u20131304","journal-title":"Kidney Int"},{"key":"4399_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ki.1994.31","volume":"45","author":"IB Salusky","year":"1994","unstructured":"Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD. Kidney Int 45:253\u2013258","journal-title":"Kidney Int"},{"key":"4399_CR8","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478\u20131483","journal-title":"N Engl J Med"},{"key":"4399_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"J Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100\u2013105","journal-title":"Circulation"},{"key":"4399_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5001514","volume":"70","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771\u2013780","journal-title":"Kidney Int"},{"key":"4399_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1681\/ASN.2015020152","volume":"27","author":"MR Denburg","year":"2016","unstructured":"Denburg MR, Kumar J, Jemielita T, Brooks ER, Skversky A, Portale AA, Salusky IB, Warady BA, Furth SL, Leonard MB (2016) Fracture burden and risk factors in childhood CKD: results from the CKiD cohort study. J Am Soc Nephrol 27:543\u2013550","journal-title":"J Am Soc Nephrol"},{"key":"4399_CR12","unstructured":"KDOQI Work Group (2009) KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. executive summary. Am J Kidney Dis 53:S11\u2013S104"},{"key":"4399_CR13","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1\u2013S130"},{"key":"4399_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","volume":"21","author":"G Klaus","year":"2006","unstructured":"Klaus G, Watson A, Edefonti A, Fischbach M, Ronnholm K, Schaefer F, Simkova E, Stefanidis CJ, Strazdins V, Vande Walle J, Schroder C, Zurowska A, Ekim M, European Pediatric Dialysis Working Group (EPDWG) (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21:151\u2013159","journal-title":"Pediatr Nephrol"},{"key":"4399_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00467-012-2270-1","volume":"28","author":"D Haffner","year":"2013","unstructured":"Haffner D, Schaefer F (2013) Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies. Pediatr Nephrol 28:537\u2013545","journal-title":"Pediatr Nephrol"},{"key":"4399_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00467-007-0684-y","volume":"23","author":"L Rees","year":"2008","unstructured":"Rees L (2008) What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? Pediatr Nephrol 23:179\u2013184","journal-title":"Pediatr Nephrol"},{"key":"4399_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0022-3476(80)80479-3","volume":"97","author":"ME Norman","year":"1980","unstructured":"Norman ME, Mazur AT, Borden S, Gruskin A, Anast C, Baron R, Rasmussen H (1980) Early diagnosis of juvenile renal osteodystrophy. J Pediatr 97:226\u2013232","journal-title":"J Pediatr"},{"key":"4399_CR18","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.2215\/CJN.01330210","volume":"5","author":"SA Bakkaloglu","year":"2010","unstructured":"Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang HJ, Elashoff RM, Salusky IB (2010) Value of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol 5:1860\u20131866","journal-title":"Clin J Am Soc Nephrol"},{"key":"4399_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04810515","volume":"11","author":"RC Pereira","year":"2016","unstructured":"Pereira RC, Bischoff DS, Yamaguchi D, Salusky IB, Wesseling-Perry K (2016) Micro-CT in the assessment of pediatric renal osteodystrophy by bone histomorphometry. Clin J Am Soc Nephrol 11:481\u2013487","journal-title":"Clin J Am Soc Nephrol"},{"key":"4399_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00467-012-2347-x","volume":"28","author":"R Shroff","year":"2013","unstructured":"Shroff R (2013) Phosphate is a vascular toxin. Pediatr Nephrol 28:583\u2013593","journal-title":"Pediatr Nephrol"},{"key":"4399_CR21","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1681\/ASN.2006121397","volume":"18","author":"RC Shroff","year":"2007","unstructured":"Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18:2996\u20133003","journal-title":"J Am Soc Nephrol"},{"key":"4399_CR22","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s00467-006-0159-6","volume":"21","author":"M Civilibal","year":"2006","unstructured":"Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21:1426\u20131433","journal-title":"Pediatr Nephrol"},{"key":"4399_CR23","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/ndt\/gfl098","volume":"21","author":"S Briese","year":"2006","unstructured":"Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke KD, Andreae J, Haffner D, Querfeld U (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906\u20131914","journal-title":"Nephrol Dial Transplant"},{"key":"4399_CR24","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1097\/01.ASN.0000037677.16961.DF","volume":"13","author":"JW Groothoff","year":"2002","unstructured":"Groothoff JW, Gruppen MP, Offringa M, de Groot E, Stok W, Bos WJ, Davin JC, Lilien MR, Van de Kar NC, Wolff ED, Heymans HS (2002) Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13:2953\u20132961","journal-title":"J Am Soc Nephrol"},{"key":"4399_CR25","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1681\/ASN.2005030291","volume":"16","author":"MM Mitsnefes","year":"2005","unstructured":"Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2005) Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J Am Soc Nephrol 16:2796\u20132803","journal-title":"J Am Soc Nephrol"},{"key":"4399_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607\u2013617","journal-title":"Am J Kidney Dis"},{"key":"4399_CR27","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","volume":"22","author":"N Voormolen","year":"2007","unstructured":"Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, Boeschoten EW, Huisman RM, Krediet RT, Dekker FW, PREPARE study group (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22:2909\u20132916","journal-title":"Nephrol Dial Transplant"},{"key":"4399_CR28","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","volume":"90","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel P, Bover J, Urena Torres P (2016) Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int 90:1184\u20131190","journal-title":"Kidney Int"},{"key":"4399_CR29","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1210\/jc.2009-1909","volume":"95","author":"K Wesseling-Perry","year":"2010","unstructured":"Wesseling-Perry K, Harkins GC, Wang HJ, Elashoff R, Gales B, Horwitz MJ, Stewart AF, Juppner H, Salusky IB (2010) The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84). J Clin Endocrinol Metab 95:2772\u20132780","journal-title":"J Clin Endocrinol Metab"},{"key":"4399_CR30","doi-asserted-by":"publisher","first-page":"e40242","DOI":"10.1371\/journal.pone.0040242","volume":"7","author":"B Hocher","year":"2012","unstructured":"Hocher B, Armbruster FP, Stoeva S, Reichetzeder C, Gron HJ, Lieker I, Khadzhynov D, Slowinski T, Roth HJ (2012) Measuring parathyroid hormone (PTH) in patients with oxidative stress\u2014do we need a fourth generation parathyroid hormone assay? PLoS One 7:e40242","journal-title":"PLoS One"},{"key":"4399_CR31","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1172\/JCI110106","volume":"67","author":"KA Hruska","year":"1981","unstructured":"Hruska KA, Korkor A, Martin K, Slatopolsky E (1981) Peripheral metabolism of intact parathyroid hormone. Role of liver and kidney and the effect of chronic renal failure. J Clin Invest 67:885\u2013892","journal-title":"J Clin Invest"},{"key":"4399_CR32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40620-017-0408-8","volume":"30","author":"MG Vervloet","year":"2017","unstructured":"Vervloet MG, Brandenburg VM, CKD-MBD working group of ERA-EDTA (2017) Circulating markers of bone turnover. J Nephrol 30:663\u2013670","journal-title":"J Nephrol"},{"key":"4399_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1681\/ASN.2014020169","volume":"26","author":"GM London","year":"2015","unstructured":"London GM, Marchais SJ, Guerin AP, de Vernejoul MC (2015) Ankle-brachial index and bone turnover in patients on dialysis. J Am Soc Nephrol 26:476\u2013483","journal-title":"J Am Soc Nephrol"},{"key":"4399_CR34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00467-003-1091-7","volume":"18","author":"CP Schmitt","year":"2003","unstructured":"Schmitt CP, Ardissino G, Testa S, Claris-Appiani A, Mehls O (2003) Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 18:440\u2013444","journal-title":"Pediatr Nephrol"},{"key":"4399_CR35","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00467-006-0348-3","volume":"22","author":"J Cansick","year":"2007","unstructured":"Cansick J, Waller S, Ridout D, Rees L (2007) Growth and PTH in prepubertal children on long-term dialysis. Pediatr Nephrol 22:1349\u20131354","journal-title":"Pediatr Nephrol"},{"key":"4399_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D'Haese PC, Drueke TB, Du H, Manley T, Rojas E, Moe SM (2016) Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis 67:559\u2013566","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"4399_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/nep.13017","volume":"22","author":"T Diamond","year":"2017","unstructured":"Diamond T, Elder GJ (2017) Is there a practical role for bone biopsy in chronic kidney disease? Nephrology (Carlton) 22(Suppl 2):22\u201326","journal-title":"Nephrology (Carlton)"},{"key":"4399_CR38","doi-asserted-by":"publisher","unstructured":"Lalayiannis AD, Crabtree NJ, Fewtrell M, Biassoni L, Milford DV, Ferro CJ, Shroff R (2019) Assessing bone mineralisation in children with chronic kidney disease: what clinical and research tools are available? Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-019-04271-1","DOI":"10.1007\/s00467-019-04271-1"},{"key":"4399_CR39","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.kint.2018.12.014","volume":"95","author":"P Sanchis","year":"2019","unstructured":"Sanchis P, Ho CY, Liu Y, Beltran LE, Ahmad S, Jacob AP, Furmanik M, Laycock J, Long DA, Shroff R, Shanahan CM (2019) Arterial \"inflammaging\" drives vascular calcification in children on dialysis. Kidney Int 95:958\u2013972","journal-title":"Kidney Int"},{"key":"4399_CR40","doi-asserted-by":"publisher","unstructured":"Querfeld U, Schaefer F (2018) Cardiovascular risk factors in children on dialysis: an update. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-018-4125-x","DOI":"10.1007\/s00467-018-4125-x"},{"key":"4399_CR41","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2215\/CJN.04260413","volume":"8","author":"GA Block","year":"2013","unstructured":"Block GA, Kilpatrick RD, Lowe KA, Wang W, Danese MD (2013) CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis. Clin J Am Soc Nephrol 8:2132\u20132140","journal-title":"Clin J Am Soc Nephrol"},{"key":"4399_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters. Kidney Int 92:26\u201336","journal-title":"Kidney Int"},{"key":"4399_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1681\/ASN.2013010103","volume":"25","author":"AY Wang","year":"2014","unstructured":"Wang AY, Fang F, Chan J, Wen YY, Qing S, Chan IH, Lo G, Lai KN, Lo WK, Lam CW, Yu CM (2014) Effect of paricalcitol on left ventricular mass and function in CKD\u2014the OPERA trial. J Am Soc Nephrol 25:175\u2013186","journal-title":"J Am Soc Nephrol"},{"key":"4399_CR44","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Packham D, Singh B, Zehnder D, Shah A, Pachika A, Manning WJ, Solomon SD (2012) Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: The PRIMO randomized controlled trial. JAMA 307:674\u2013684","journal-title":"JAMA"},{"key":"4399_CR45","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"EVOLVE Trial Investigators","year":"2012","unstructured":"Trial Investigators EVOLVE, Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2482\u20132494","journal-title":"N Engl J Med"},{"key":"4399_CR46","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00467-016-3505-3","volume":"32","author":"D Haffner","year":"2017","unstructured":"Haffner D, Leifheit-Nestler M (2017) Extrarenal effects of FGF23. Pediatr Nephrol 32:753\u2013765","journal-title":"Pediatr Nephrol"},{"key":"4399_CR47","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/01.hjh.0000166849.72721.1c","volume":"23","author":"D Haffner","year":"2005","unstructured":"Haffner D, Hocher B, Muller D, Simon K, Konig K, Richter CM, Eggert B, Schwarz J, Godes M, Nissel R, Querfeld U (2005) Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3. J Hypertens 23:1067\u20131075","journal-title":"J Hypertens"},{"key":"4399_CR48","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00467-018-4116-y","volume":"34","author":"BA Warady","year":"2019","unstructured":"Warady BA, Iles JN, Ariceta G, Dehmel B, Hidalgo G, Jiang X, Laskin B, Shahinfar S, Vande Walle J, Schaefer F (2019) A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis. Pediatr Nephrol 34:475\u2013486","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04399-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-019-04399-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04399-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T23:25:59Z","timestamp":1610061959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-019-04399-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4399"],"URL":"https:\/\/doi.org\/10.1007\/s00467-019-04399-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"assertion":[{"value":"26 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DH and MLN received a research grant from Amgen. DH received consultant fees from Amgen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}